Ex vivo gene transfer of viral interleukin-10 to BB rat islets: No protection after transplantation to diabetic BB rats

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 4, 2007, Pages 868-880

  Kuttler, Beate ^a   Wanka, Heike ^a   Klöting, Nora ^a,b   Gerstmayer, Bernhard ^c   Volk, Hans Dieter ^d   Sawitzki, Birgit ^d   Ritter, Thomas ^d,e  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c MILTENYI BIOTEC GMBH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Adenoviral construct; Autoimmune islet destruction; BB rats; cDNA microarray; Ex vivo gene transfer; Islet transplantation; Viral interleukin 10

Indexed keywords

FAS ANTIGEN; INSULIN; INTERLEUKIN 10; STREPTOZOCIN;

ADENOVIRUS; ANIMAL; ARTICLE; AUTOIMMUNITY; BIOBREEDING RAT; CLUSTER ANALYSIS; DNA MICROARRAY; EPSTEIN BARR VIRUS; EXPERIMENTAL DIABETES MELLITUS; FLOW CYTOMETRY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; LEWIS RAT; METABOLISM; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; RAT;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD95; AUTOIMMUNITY; BLOOD GLUCOSE; CLUSTER ANALYSIS; DIABETES MELLITUS, EXPERIMENTAL; FLOW CYTOMETRY; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; INSULIN; INTERLEUKIN-10; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED BB; RATS, INBRED LEW; STREPTOZOCIN; TRANSDUCTION, GENETIC;

RATTUS;

EID: 34548156165     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00059.x     Document Type: Article

References (50)

1. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001 19 : 683 765.
2. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes viadownregulation of class II major histocompatibility complex expression. J Exp Med. 1991 174 : 915 24.
3. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991 174 : 1209 20.
4. Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min HY, Lin L. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol. 1992 148 : 808 14.
5. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med. 1993 178 : 2207 11.
6. Qin L, Ding Y, Pahud DR, Robson ND, Shaked A, Bromberg JS. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther. 1997 8 : 1365 74.
7. Ding Y, Qin L, Kotenko SV, Pestka S, Bromberg JS. A single amino acid determines the immunostimulatory activity of interleukin 10. J Exp Med. 2000 191 : 213 24.
8. Gojo S, Cooper DK, Iacomini J, LeGuern C. Gene therapy and transplantation. Transplantation. 2000 69 : 1995 9.
9. Guillot C, Le Mauff B, Cuturi MC, Anegon I. Gene therapy in transplantation in the year 2000: moving towards clinical applications? Gene Ther. 2000 7 : 14 9.
10. David A, Chetritt J, Guillot C, Tesson L, Heslan JM, Cuturi MC, Soulillou JP, Anegon I. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther. 2000 7 : 505 10.
11. Brauner R, Nonoyama M, Laks H, Drinkwater DC, Jr., McCaffery S, Drake T, Berk AJ, Sen L, Wu L. Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival. J Thorac Cardiovasc Surg. 1997 114 : 923 33.
12. DeBruyne LA, Li K, Chan SY, Qin L, Bishop DK, Bromberg JS. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Ther. 1998 5 : 1079 87.
13. Gong N, Pleyer U, Volk HD, Ritter T. Effects of local and systemic viral interleukin-10 gene transfer on corneal allograft survival. Gene Ther. 2007 14 : 484 90.
14. Goudy K, Song S, Wasserfall C, Zhang YC, Kapturczak M, Muir A, Powers M, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Ellis TM, Flotte TR, Atkinson MA. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc Natl Acad Sci USA. 2001 98 : 13913 8.
15. Goudy KS, Burkhardt BR, Wasserfall C, Song S, Campbell-Thompson ML, Brusko T, Powers MA, Clare-Salzler MJ, Sobel ES, Ellis TM, Flotte TR, Atkinson MA. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J Immunol. 2003 171 : 2270 8.
16. Yang Z, Chen M, Wu R, Fialkow LB, Bromberg JS, McDuffie M, Naji A, Nadler JL. Suppression of autoimmune diabetes by viral IL-10 gene transfer. J Immunol. 2002 168 : 6479 85.
17. Zhang YC, Pileggi A, Agarwal A, Molano RD, Powers M, Brusko T, Wasserfall C, Goudy K, Zahr E, Poggioli R, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Nick H, Flotte T, Ellis TM, Ricordi C, Inverardi L, Atkinson MA. Adenoassociated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes. 2003 52 : 708 16.
18. Zhang YC, Pileggi A, Molano RD, Wasserfall C, Campbell-Thompson M, Ricordi C, Atkinson MA, Inverardi L. Systemic overexpression of interleukin-10 fails to protect allogeneic islet transplants in nonobese diabetic mice. Transplantation. 2005 80 : 530 3.
19. Carter JD, Ellett JD, Chen M, Smith KM, Fialkow LB, McDuffie MJ, Tung KS, Nadler JL, Yang Z. Viral IL-10-mediated immune regulation in pancreatic islet transplantation. Mol Ther. 2005 12 : 360 8.
20. Smith DK, Korbutt GS, Suarez-Pinzon WL, Kao D, Rajotte RV, Elliott JF. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice. Transplantation. 1997 64 : 1040 9.
21. Yasuda H, Nagata M, Arisawa K, Yoshida R, Fujihira K, Okamoto N, Moriyama H, Miki M, Saito I, Hamada H, Yokono K, Kasuga M. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J Clin Invest. 1998 102 : 1807 14.
22. Kloting I, Reiher K. [Various aspects of the management and reproduction of spontaneously diabetic BB rats]. Z Versuchstierkd. 1985 27 : 5 11.
23. Hehmke B, Kohnert KD, Odselius R. The use of a new dextran gradient medium for rapid isolation of functionally intact neonatal rat pancreatic islets. Diabetes Res. 1986 3 : 13 6.
24. Kuttler B, Hartmann A, Wanka H. Long-term culture of islets abrogates cytokine-induced or lymphocyteinduced increase of antigen expression on beta cells. Transplantation. 2002 74 : 440 5.
25. Kolls J, Peppel K, Silva M, Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA. 1994 91 : 215 9.
26. Zhu Z, Stevenson D, Schechter JE, Mircheff AK, Ritter T, Labree L, Trousdale MD. Prophylactic effect of IL-10 gene transfer on induced autoimmune dacryoadenitis. Invest Ophthalmol Vis Sci. 2004 45 : 1375 81.
27. Ritter T, Vogt K, Rieck P, Schilling-Schon A, Kolls J, Hartmann C, Volk HD, Pleyer U. Adenovirusmediated gene transfer of interleukin-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res. 1999 69 : 563 8.
28. Kohnert KD, Hehmke B. Preparation of suspensions of pancreatic islet cells: a comparison of methods. J Biochem Biophys Methods. 1986 12 : 81 8.
29. Kuttler B, Rosing K, Hahn HJ. Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats. Transplant Proc. 1997 29 : 2163 5.
30. Hahn HJ. [The isolated islet of Langerhans, a model for insulin secretion in vitro]. Endokrinologie. 1978 71 : 308 24.
31. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol. 2006 36 : 1309 23.
32. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 1995 69 : 2004 15.
33. Zhang N, Schroppel B, Chen D, Fu S, Hudkins KL, Zhang H, Murphy BM, Sung RS, Bromberg JS. Adenovirus transduction induces expression of multiple chemokines and chemokine receptors in murine beta cells and pancreatic islets. Am J Transplant. 2003 3 : 1230 41.
34. Breit SN, Wakefield D, Robinson JP, Luckhurst E, Clark P, Penny R. The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol. 1985 35 : 363 80.
35. Song S, Goudy K, Campbell-Thompson M, Wasserfall C, Scott-Jorgensen M, Wang J, Tang Q, Crawford JM, Ellis TM, Atkinson MA, Flotte TR. Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther. 2004 11 : 181 6.
36. Lewis EC, Shapiro L, Bowers OJ, Dinarello CA. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA. 2005 102 : 12153 8.
37. Lu Y, Tang M, Wasserfall C, Kou Z, Campbell-Thompson M, Gardemann T, Crawford J, Atkinson M, Song S. Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Hum Gene Ther. 2006 17 : 625 34.
38. Suarez-Pinzon WL, Marcoux Y, Ghahary A, Rabinovitch A. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction. Cell Transplant. 2002 11 : 519 28.
39. Uchikoshi F, Yang ZD, Rostami S, Yokoi Y, Capocci P, Barker CF, Naji A. Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes. 1999 48 : 652 7.
40. Nakamura Y, Yasunami Y, Satoh M, Hirakawa E, Katsuta H, Ono J, Kamada M, Todo S, Nakayama T, Taniguchi M, Ikeda S. Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator. Transplantation. 2003 75 : 1115 8.
41. Muruve DA, Nicolson AG, Manfro RC, Strom TB, Sukhatme VP, Libermann TA. Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after Systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts. Hum Gene Ther. 1997 8 : 955 63.
42. Judge TA, Desai NM, Yang Z, Rostami S, Alonso L, Zhang H, Chen Y, Markman JF, DeMateo RP, Barker CF, Naji A, Turka LA. Utility of adenoviralmediated Fas ligand gene transfer to modulate islet allograft survival. Transplantation. 1998 66 : 426 34.
43. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med. 1997 3 : 738 43.
44. Cai SR, He YL, Huang MJ, Peng JS, Wang JP, Zhan WH. The effect of FasL gene transfer to islet cells on pancreatic islet allografts. Hepatobiliary Pancreat Dis Int. 2003 2 : 308 12.
45. Machen J, Bertera S, Chang Y, Bottino R, Balamurugan AN, Robbins PD, Trucco M, Giannoukakis N. Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy. Gene Ther. 2004 11 : 1506 14.
46. Ritter T, Schroder G, Risch K, Vergopoulos A, Shean MK, Kolls J, Brock J, Lehmann M, Volk HD. Ischemia/reperfusion injury-mediated down-regulation of adenovirus-mediated gene expression in a rat heart transplantation model is inhibited by co-application of a TNFRp55-Ig chimeric construct. Gene Ther. 2000 7 : 1238 43.
47. Hahn HJ, Kuttler B, Dunger A, Kloting I, Lucke S, Volk HD, von Baehr R, Diamantstein T. Prolongation of rat pancreatic islet allograft survival by treatment of recipient rats with monoclonal antiinterleukin- 2 receptor antibody and cyclosporin. Diabetologia. 1987 30 : 44 6.
48. Hahn HJ, Kauert C, Dunger A, Kuttler B, Diamantstein T. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets. Autoimmunity. 1989 5 : 139 42.
49. Kuttler B, Rosing K, Lehmann M, Brock J, Hahn HJ. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies. J Mol Med. 1999 77 : 226 9.
50. Kuttler B, Dunger A, Volk HD, Diamantstein T, Hahn HJ. Prevention and suppression of autoimmune pancreatic beta-cell destruction in BB rats by syngeneic lymphocytes obtained from long-term normoglycaemic donors. Diabetologia. 1991 34 : 74 7.